Four things to know:
1. Allscripts expects to grow its provider space, which comprises EHRs in both the acute and ambulatory settings, 2.5 percent to 3 percent by 2022.
2. The company’s payer and life sciences division Veradigm is projected to increase at a compound annual growth rate of 15 percent to 25 percent over the next three years. Based on that estimation, Allscripts aims secure a 3.5 percent to 6 percent non-GAAP growth rate.
3. Allscripts plans to increase its merger and acquisition revenues by 2 percent to 3 percent over the next three years.
4. Collectively, the company anticipates growing its revenues at a 5.5 percent to 9 percent CAGR by 2022.
More articles on EHRs:
Nearly 1 in 3 eye care patients’ EHR may pose medication discrepancy, study finds
Physician viewpoint: Surgeons ‘shielded’ from certain paperwork, administrative tasks that cause burnout
HIMSS’ EHR association raises concerns about ONC’s proposed interoperability rule
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.